FDA Approved: BUPROPION HYDROCHLORIDE (SR) — Original Application (Cipla USA Inc.,)

View source ↗

Summary

The FDA approves Cipla USA Inc.'s original application for a generic sustained-release formulation of bupropion hydrochloride (SR).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder
• Seasonal Affective Disorder
• Smoking Cessation

Drugs mentioned

• Bupropion HCl (SR) (Bupropion hydrochloride sustained-release)

Snippet

ORIG AP for BUPROPION HYDROCHLORIDE (SR) (BUPROPION HYDROCHLORIDE)